ATRC AtriCure Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATRC

Price (delayed)

$22.1

Market cap

$1.07B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.8

Enterprise value

$1.08B

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure ...

Highlights
The company's gross profit rose by 20% YoY and by 3.9% QoQ
ATRC's revenue is up by 19% year-on-year and by 3.8% since the previous quarter
AtriCure's EPS has decreased by 21% from the previous quarter but it has increased by 2.4% YoY
AtriCure's quick ratio has decreased by 10% YoY but it has increased by 3.1% QoQ
ATRC's net income is down by 22% QoQ
The equity has contracted by 2.1% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.atricure.com
Peers: TFX EW BSX COO

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
48.38M
Market cap
$1.07B
Enterprise value
$1.08B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.3
Price to sales (P/S)
2.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.6
Earnings
Revenue
$414.6M
EBIT
-$29.57M
EBITDA
-$13.25M
Free cash flow
-$54.72M
Per share
EPS
-$0.8
Free cash flow per share
-$1.17
Book value per share
$9.59
Revenue per share
$8.87
TBVPS
$6.31
Balance sheet
Total assets
$591.63M
Total liabilities
$135.32M
Debt
$75.36M
Equity
$456.31M
Working capital
$183.97M
Liquidity
Debt to equity
0.17
Current ratio
4
Quick ratio
2.63
Net debt/EBITDA
-0.78
Margins
EBITDA margin
-3.2%
Gross margin
75.3%
Net margin
-9%
Operating margin
-7.7%
Efficiency
Return on assets
-6.2%
Return on equity
-8.1%
Return on invested capital
-12.9%
Return on capital employed
-5.6%
Return on sales
-7.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
-6.08%
1 week
-8.56%
1 month
-3.91%
1 year
-61.72%
YTD
-38.08%
QTD
-2.94%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$414.6M
Gross profit
$312.03M
Operating income
-$31.82M
Net income
-$37.23M
Gross margin
75.3%
Net margin
-9%
ATRC's net income is down by 22% QoQ
The operating margin has grown by 21% year-on-year but it has declined by 15% since the previous quarter
The company's gross profit rose by 20% YoY and by 3.9% QoQ
The operating income has decreased by 19% from the previous quarter but it has increased by 7% YoY

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
2.3
P/S
2.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.6
AtriCure's EPS has decreased by 21% from the previous quarter but it has increased by 2.4% YoY
ATRC's price to book (P/B) is 53% lower than its 5-year quarterly average of 5.2 and 40% lower than its last 4 quarters average of 4.1
The equity has contracted by 2.1% from the previous quarter
ATRC's P/S is 66% below its 5-year quarterly average of 7.8 and 45% below its last 4 quarters average of 4.8
ATRC's revenue is up by 19% year-on-year and by 3.8% since the previous quarter

Efficiency

How efficient is AtriCure business performance
The company's return on invested capital fell by 29% QoQ and by 8% YoY
AtriCure's ROS has decreased by 25% from the previous quarter but it has increased by 22% YoY
The ROE has contracted by 23% from the previous quarter but it has grown by 2.4% YoY
AtriCure's return on assets has decreased by 22% QoQ but it has increased by 4.6% YoY

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
The current ratio is up by 12% since the previous quarter and by 5% year-on-year
AtriCure's quick ratio has decreased by 10% YoY but it has increased by 3.1% QoQ
The debt is 83% less than the equity
The debt to equity has grown by 6% since the previous quarter
The equity has contracted by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.